Muscle Insulin Resistance in Aging (Mirage)

N/AActive Not RecruitingNCT02230839

AdventHealth Translational Research Institute200 enrolled

Overview

The purpose of this study is to provide information regarding potential factors underlying metabolic dysfunction, insulin resistance, and loss of muscle mass in aging muscle.

Study Objectives: 1. To determine the effects of diet-induced weight loss with and without the addition of exercise on mitochondrial biogenesis and energetic capacity, cellular redox state and insulin resistance. 2. To determine the effects of diet-induced weight loss with and without the addition of exercise on intramyocellular lipid profiles. 3. To determine the effects of diet-induced weight loss with and without exercise on skeletal muscle proteins mediating a program of autophagy and either loss or maintenance of muscle mass.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

BASIC_SCIENCE

Masking

NONE

Enrollment

200

Conditions

Insulin Resistance Sarcopenia

Interventions

ExerciseBEHAVIORAL

Participants will complete a progressive 6-month exercise training program, 4-5 days per week, 45 min per session (180 min per week), consisting mostly of walking (both outside and on an indoor treadmill) but with the option to include stationary cycling, elliptical and rowing machines, similar to what we have utilized previously to elicit significant improvements in insulin sensitivity in both middle-age and older adults (52-55). Beginning at week 8, these subjects will also perform 2 non-consecutive resistance exercise sessions per week, 30 min per session, focused on major muscle groups using resistance machines (total days of exercise will still be 4 to 5).

Energy Restriction-Induced Weight LossBEHAVIORAL

The goal of the weight loss intervention will be to produce a weight loss of 10% body weight. A reduction of 500-1000 kcal/day - based on baseline weight -and low fat (\<30% of calories from fat) diet will be used as part of the weight loss intervention.

Eligibility

Sex: ALLMin age: 65 YearsMax age: 80 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * 65-80 years of age * Stable weight (No Gain/Loss of \>10 lbs in 6 months) * Sedentary (≤ 1 continuous exercise/week) * Non-smoker * BMI ≥ 30 kg/m2 * Resting Blood Pressure ≤ 150 millimeters of mercury systolic and ≤ 95 millimeters of mercury diastolic * Note from Primary care physician/Cardiologist for exercise clearance if positive stress test symptoms were observed from exercise test * Must be willing to washout for 14 days from all diabetes medication and independent in self blood glucose monitoring during the washout periods (those with diabetes only) Exclusion Criteria: * Clinically significant cardiovascular disease including history of myocardial infarction, within the past year * Peripheral Vascular Disease * Hepatic, renal, muscular/neuromuscular, or active hematologic/oncologic disease * Clinically diminished pulse * Presence of bruits in lower extremities * Previous history of pulmonary emboli * Peripheral Neuropathy

Locations (1)

Translational Research Institute for Metabolism and Diabetes

Orlando, Florida, United States

Outcomes

Primary Outcomes

Measure of intramyocellular lipids

A percutaneous muscle biopsy of the vastus lateralis will be obtained, and the intramyocellular lipids will be measured by high-performance liquid chromatography-tandem mass spectrometry.

Time frame: Visit 3 ~22 hours

Secondary Outcomes

Measure of insulin sensitivity

Insulin sensitivity will be measured using an intravenous catheter (glucose clamps) that will be placed in the antecubital vein for subsequent insulin and glucose infusions and for stable isotope infusions. This will measure insulin-stimulated changes in insulin signaling proteins and metabolism.

Time frame: Visit 3 ~22 hours

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.